Forager Capital proposes $4.80 per share buyout of Repay Holdings

Forager Capital Management, which owns about 13% of Repay Holdings, made a non-binding $4.80 per share all-cash takeover proposal, implying a 75% premium to RPAY's 30-day VWAP of $2.75. The offer targets 100% of the company, is reportedly not subject to a financing condition, and would proceed through a negotiated merger with customary regulatory and due diligence requirements. The news adds an activist-driven strategic alternative for Repay while the company separately faces investor pushback over its planned $372 million KUBRA acquisition.

Analysis

This is less a clean takeout than a three-way control battle between an opportunistic sponsor, an embattled board, and shareholders who are already signaling fatigue with execution risk. The bid creates an immediate valuation anchor well above the current trading level, but the real second-order effect is that it forces a reassessment of the KUBRA deal: if management was relying on a transformative acquisition to justify a higher multiple, a credible cash bid can make the market question whether that strategy is creating value or simply increasing complexity and integration risk.

The biggest winner is the activist/arb community, because the path of least resistance is now either a negotiated sale or a re-rating toward bid value if diligence advances. The biggest loser is the board’s strategic optionality; once a financing-backed proposal is public, every incremental step on KUBRA has to clear a higher bar, and any sign of dilution, leverage stress, or customer churn could widen the spread quickly. That matters because in small-cap payments, investor confidence is highly path-dependent: a single governance shock can compress the multiple for months even if fundamentals remain intact.

The key risk is that this becomes a prolonged process rather than a near-term takeout. Non-binding capital-light bids often look compelling, but the spread can remain wide if the board uses process tactics, if diligence exposes merchant attrition or cross-sell fragility, or if the competing transaction becomes a poison pill for buyers. Conversely, a deal for the company would likely be structurally more attractive than public-market ownership because private control can absorb integration noise and governance costs that public investors punish immediately.

Consensus is probably underestimating how little room the board has to defend status quo valuation if the KUBRA deal is not already clearly accretive. The market is likely to price RPAY as a special situation with downside protection rather than as a standalone compounder, while QIPT-style sponsor execution improves credibility for the bidder. The overdone part may be assuming the first bid sets a floor at $4.80; in reality, it sets a negotiation band, and the stock can trade below the headline unless there is rapid board engagement or a topping-bid process.

Key Decisions for Investors

• Go long RPAY common or call spreads for the next 4-8 weeks, targeting the gap between current trading and the bid price; risk/reward is favorable if the board opens talks, but size modestly because process risk can keep the spread wide.
• Buy RPAY January upside calls / call spreads as a catalyst vehicle; this limits downside if the board rejects the proposal while preserving convexity into a formal offer, topping bid, or activist pressure campaign.
• If already long RPAY, hedge event risk with a short-dated put spread into any board communication date; the main downside is a failed process plus KUBRA execution anxiety, which could re-rate the stock lower even absent a deal collapse.
• Consider a relative-value trade: long RPAY vs. short a small-cap payments/fintech peer with similar execution risk, to isolate event-driven upside from sector beta.
• Avoid shorting RPAY outright until the board response is known; the optionality skew is asymmetric because any credible negotiation or competing interest can force a fast repricing toward the offer range.